- Home
- IPSC vs RPTX Comparison
IPSC vs RPTX Comparison
Compare IPSC & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- RPTX
- Stock Information
- Founded
- IPSC 2019
- RPTX 2016
- Country
- IPSC United States
- RPTX Canada
- Employees
- IPSC N/A
- RPTX N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- IPSC Health Care
- RPTX Health Care
- Exchange
- IPSC Nasdaq
- RPTX Nasdaq
- Market Cap
- IPSC 58.1M
- RPTX 53.2M
- IPO Year
- IPSC 2021
- RPTX 2020
- Fundamental
- Price
- IPSC $0.48
- RPTX $1.01
- Analyst Decision
- IPSC Strong Buy
- RPTX Strong Buy
- Analyst Count
- IPSC 5
- RPTX 3
- Target Price
- IPSC $4.67
- RPTX $4.50
- AVG Volume (30 Days)
- IPSC 480.0K
- RPTX 221.9K
- Earning Date
- IPSC 03-19-2025
- RPTX 03-03-2025
- Dividend Yield
- IPSC N/A
- RPTX N/A
- EPS Growth
- IPSC N/A
- RPTX N/A
- EPS
- IPSC N/A
- RPTX N/A
- Revenue
- IPSC $6,589,000.00
- RPTX $53,477,000.00
- Revenue This Year
- IPSC N/A
- RPTX N/A
- Revenue Next Year
- IPSC N/A
- RPTX $7.11
- P/E Ratio
- IPSC N/A
- RPTX N/A
- Revenue Growth
- IPSC 194.81
- RPTX 4.58
- 52 Week Low
- IPSC $0.47
- RPTX $0.98
- 52 Week High
- IPSC $4.43
- RPTX $4.77
- Technical
- Relative Strength Index (RSI)
- IPSC 26.49
- RPTX 33.72
- Support Level
- IPSC $0.54
- RPTX $0.98
- Resistance Level
- IPSC $0.59
- RPTX $1.09
- Average True Range (ATR)
- IPSC 0.05
- RPTX 0.06
- MACD
- IPSC -0.00
- RPTX -0.00
- Stochastic Oscillator
- IPSC 3.08
- RPTX 15.87
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.